42 results
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
16 Apr 24
Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update
4:20pm
opinion leader in the healthcare sector, in February 2024 to the Company’s Board of Directors.
Anticipated Upcoming Milestones
The Company has scheduled
6-K
CNTB
Connect Biopharma Holdings Ltd
12 Feb 24
Current report (foreign)
4:50pm
, a life science focused investment firm with a focus on investments in innovative and transformative early and growth stage healthcare and life
144
RA Capital Nexus Fund, L.P.
18 Dec 23
Notice of proposed sale of securities
6:44pm
>
RA Capital Healthcare Fund LP
RA Capital Healthcare
144
CNTB
Connect Biopharma Holdings Ltd
18 Dec 23
Notice of proposed sale of securities
6:09pm
144
cfzs ac8h
12 Dec 23
Notice of proposed sale of securities
7:40pm
144
t97mris
12 Dec 23
Notice of proposed sale of securities
7:05pm
144
z7ttobsi7hhz
27 Nov 23
Notice of proposed sale of securities
7:49pm
144
lrbb0xhmd5bu62an4sq
27 Nov 23
Notice of proposed sale of securities
7:32pm
144
h5cu3s0k
21 Nov 23
Notice of proposed sale of securities
6:58pm
6-K
EX-99.1
q8u bkm8h
5 Jun 23
Current report (foreign)
4:28pm
6-K
2k0hpmpqqtmwteb710m2
13 Sep 22
Connect Biopharma Reports First Half 2022 Financial Results
4:47pm
F-3/A
pb8uzzwv
17 Jun 22
Shelf registration (foreign) (amended)
5:19pm
6-K
EX-99.1
2a3w7lwwvrbaa9z
10 Jun 22
Current report (foreign)
6:05am
6-K
enx 377wuan
10 Jun 22
Current report (foreign)
6:05am
F-3/A
2t4qyrwhhzc8
20 May 22
Shelf registration (foreign) (amended)
6:54pm
6-K
EX-99.2
vd0kndkjorvj1w
3 May 22
Connect Biopharma Announces Week 12 Top-Line Results from Phase 2 CBP-307 Trial in Patients with Moderate-to-Severe Ulcerative Colitis
4:36pm
F-3
EX-1.2
te7qcs0
15 Apr 22
Shelf registration (foreign)
5:27pm
F-3
afan1zy257 83q0cw
15 Apr 22
Shelf registration (foreign)
5:27pm